Recherche
-
COVID-19: France grapples with the pragmatics of isolation
(Lancet Public Health. vol. 5, n° 11, pp. E573-E574, 2020)Article de revueLibre accès -
Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort
(BMC Infectious Diseases. vol. 20, n° 1, pp. 850, 2020-11-16)Article de revueLibre accès -
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials
(CPT: Pharmacometrics and Systems Pharmacology, 2020)Article de revueLibre accès -
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load
(CPT: Pharmacometrics and Systems Pharmacology. vol. 9, n° 9, pp. 509-514, 2020-09)Article de revueLibre accès -
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
(PLoS Neglected Tropical Diseases. vol. 14, n° 6, pp. e0008259, 2020)Article de revueLibre accès -
Dermatoses in international travellers seen at Bordeaux teaching hospital travel clinic, 2015-2018: a GeoSentinel-based study
(Clinical and Experimental Dermatology. vol. 45, n° 5, pp. 580-583, 2020)Article de revueLibre accès -
A new trajectory approach for investigating the association between an environmental or occupational exposure over lifetime and the risk of chronic disease: Application to smoking, asbestos, and lung cancer
(PLoS ONE. vol. 15, n° 8, pp. e0236736, 2020)Article de revueLibre accès -
Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary study
(Health Qual Life Outcomes. vol. 18, n° 1, pp. 220, 2020)Article de revueLibre accès -
Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)
(Nutrients. vol. 12, n° 9, 2020-08-21)Article de revueLibre accès -
Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)
(Trials. vol. 21, n° 1, pp. 846, 2020-10-13)Article de revueLibre accès